Association of biochemical parameters and RAGE gene polymorphisms in healthy infants and their mothers

Clinica Chimica Acta

Volumn 411, Issue 1-16, 2010, Pages 1034-1040

  Boor, P ^a,b   Celec, P ^c   Klenovicsova K ^a,c   Vlkova B ^c   Szemes, T ^c   Minarik G ^c   Turna J ^c   Sebekova K ^a  

^a SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c Physics and Informatics   (Slovakia)

Author keywords

Advanced glycation end products (AGEs); Ager SNP; Insulin resistance; Nutrigenomics; SICAM 1; SRAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; GLUCOSE; GLYCINE; HIGH DENSITY LIPOPROTEIN; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SERINE;

ARTICLE; ARTIFICIAL MILK; BLOOD CHEMISTRY; BREAST MILK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; INFANT; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NEWBORN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; DIET; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEALTH; HUMANS; INFANT; INFANT FORMULA; INFLAMMATION; MALE; MILK, HUMAN; MOTHERS; PHENOTYPE; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RECEPTORS, IMMUNOLOGIC;

EID: 77953291663     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.03.033     Document Type: Article

References (36)

1. Kalousova M., Zima T., Tesar V., Dusilova-Sulkova S., Skrha J. Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background. Mutat Res 2005, 579:37-46.
2. Bierhaus A., Humpert P.M., Morcos M., et al. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 2005, 83:876-886.
3. Boulanger E., Wautier M.P., Wautier J.L., et al. AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression. Kidney Int 2002, 61:148-156.
4. Schmidt A.M., Hori O., Chen J.X., et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 1995, 96:1395-1403.
5. Hudson B.I., Bucciarelli L.G., Wendt T., et al. Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders. Arch Biochem Biophys 2003, 419:80-88.
6. Sebekova K., Somoza V. Dietary advanced glycation endproducts (AGEs) and their health effects-PRO. Mol Nutr Food Res 2007, 51:1079-1084.
7. Sebekova K., Saavedra G., Zumpe C., Somoza V., Klenovicsova K., Birlouez-Aragon I. Plasma concentration and urinary excretion of N epsilon-(carboxymethyl)lysine in breast milk- and formula-fed infants. Ann N Y Acad Sci 2008, 1126:177-180.
8. Hudson B.I., Stickland M.H., Grant P.J. Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups. Diabetes 1998, 47:1155-1157.
9. Pettersson-Fernholm K., Forsblom C., Hudson B.I., Perola M., Grant P.J., Groop P.H. The functional -374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients. Diabetes 2003, 52:891-894.
10. Kankova K., Stejskalova A., Hertlova M., Znojil V. Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus. Nephrol Dial Transplant 2005, 20:1093-1102.
11. Kankova K., Vasku A., Hajek D., Zahejsky J., Vasku V. Association of G82S polymorphism in the RAGE gene with skin complications in type 2 diabetes. Diabetes Care 1999, 22:1745.
12. Kankova K., Zahejsky J., Marova I., et al. Polymorphisms in the RAGE gene influence susceptibility to diabetes-associated microvascular dermatoses in NIDDM. J Diabetes Complications 2001, 15:185-192.
13. Prevost G., Fajardy I., Besmond C., et al. Polymorphisms of the receptor of advanced glycation endproducts (RAGE) and the development of nephropathy in type 1 diabetic patients. Diabetes Metab 2005, 31:35-39.
14. Prevost G., Fajardy I., Fontaine P., Danze P.M., Besmond C. Human RAGE GLY82SER dimorphism and HLA class II DRB1-DQA1-DQB1 haplotypes in type 1 diabetes. Eur J Immunogenet 1999, 26:343-348.
15. Lindholm E., Bakhtadze E., Sjogren M., et al. The -374 T/A polymorphism in the gene encoding RAGE is associated with diabetic nephropathy and retinopathy in type 1 diabetic patients. Diabetologia 2006, 49:2745-2755.
16. Kumaramanickavel G., Ramprasad V.L., Sripriya S., Upadyay N.K., Paul P.G., Sharma T. Association of Gly82Ser polymorphism in the RAGE gene with diabetic retinopathy in type II diabetic Asian Indian patients. J Diabetes Complications 2002, 16:391-394.
17. Gaens K.H., Ferreira I., van der Kallen C.J., et al. Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels. J Clin Endocrinol Metab 2009, 94:5174-5180.
18. Kankova K., Sebekova K. Genetic variability in the RAGE gene: possible implications for nutrigenetics, nutrigenomics, and understanding the susceptibility to diabetic complications. Mol Nutr Food Res 2005, 49:700-709.
19. Boor P., Celec P., Behuliak M., et al. Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats. Metabolism 2009, 58:1669-1677.
20. Jang Y., Kim J.Y., Kang S.M., et al. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans. Metabolism 2007, 56:199-205.
21. Kim O.Y., Jo S.H., Jang Y., et al. G allele at RAGE SNP82 is associated with proinflammatory markers in obese subjects. Nutr Res 2009, 29:106-113.
22. Hofmann M.A., Drury S., Hudson B.I., et al. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun 2002, 3:123-135.
23. Basta G., Sironi A.M., Lazzerini G., et al. Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein. J Clin Endocrinol Metab 2006, 91:4628-4634.
24. Lee S., Gungor N., Bacha F., Arslanian S. Insulin resistance: link to the components of the metabolic syndrome and biomarkers of endothelial dysfunction in youth. Diabetes Care 2007, 30:2091-2097.
25. Ingelsson E., Hulthe J., Lind L. Inflammatory markers in relation to insulin resistance and the metabolic syndrome. Eur J Clin Invest 2008, 38:502-509.
26. Sjogren P., Basta G., de Caterina R., et al. Markers of endothelial activity are related to components of the metabolic syndrome, but not to circulating concentrations of the advanced glycation end-product N epsilon-carboxymethyl-lysine in healthy Swedish men. Atherosclerosis 2007, 195:e168-e175.
27. Kaji Y., Usui T., Ishida S., et al. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products. Invest Ophthalmol Vis Sci 2007, 48:858-865.
28. Campo I., Morbini P., Zorzetto M., et al. Expression of receptor for advanced glycation end products in sarcoid granulomas. Am J Respir Crit Care Med 2007, 175:498-506.
29. Turck D. Breast feeding: health benefits for child and mother. Arch Pediatr 2005, 12(Suppl 3):S145-S165.
30. Das U.N. The lipids that matter from infant nutrition to insulin resistance. Prostaglandins Leukot Essent Fatty Acids 2002, 67:1-12.
31. Savino F., Fissore M.F., Liguori S.A., Oggero R. Can hormones contained in mothers' milk account for the beneficial effect of breast-feeding on obesity in children?. Clin Endocrinol (Oxf) 2009, 71:757-765.
32. Goulart A.C., Germer S., Rexrode K.M., Martin M., Zee R.Y. Polymorphisms in advanced glycosylation end product-specific receptor (AGER) gene, insulin resistance, and type 2 diabetes mellitus. Clin Chim Acta 2008, 398:95-98.
33. Gaens K.H., van Der Kallen C.J., van Greevenbroek M.M., Feskens E.J., Stehouwer C.D., Schalkwijk C.G. Receptor for advanced glycation end product polymorphisms and type 2 diabetes: the CODAM study. Ann N Y Acad Sci 2008, 1126:162-165.
34. Ekong U., Zeng S., Dun H., et al. Blockade of the receptor for advanced glycation end products attenuates acetaminophen-induced hepatotoxicity in mice. J Gastroenterol Hepatol 2006, 21:682-688.
35. Zeng S., Dun H., Ippagunta N., et al. Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury. J Hepatol 2009, 50:929-936.
36. Hudson B.I., Stickland M.H., Futers T.S., Grant P.J. Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 2001, 50:1505-1511.